SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-127514"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-127514" > Antiviral treatment...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002922naa a2200421 4500
001oai:DiVA.org:uu-127514
003SwePub
008100713s2009 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:119396952
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1275142 URI
024a https://doi.org/10.1111/j.1348-0421.2009.00160.x2 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1193969522 URI
040 a (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Holmberg, Rebecka4 aut
2451 0a Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats
264 1b Wiley,c 2009
338 a print2 rdacarrier
520 a The effects of LV in two different species, CD-1 mice, without a genetic disposition for diabetes, and BB rats prone to T1D were examined. Male CD-1 mice that had been exposed to LV in utero developed a type 2-like diabetes with increased blood glucose, insulin levels and epididymal fat at the age of 10-15 weeks. Combination therapy including LV-antiserum and an antiviral drug, Pleconaril, significantly reduced the levels of blood glucose and insulin and the amount of abdominal fat. In BB rats, LV has been found in both prediabetic- and diabetic diabetes-prone rats, as well as in diabetes-resistant rats. To evaluate whether the presence of LV has any influence on the onset of T1D, prediabetic BB rats were treated with an antiserum against LV or a combination of the antiviral drugs Pleconaril and Ribavirin. In the group treated with antiviral drugs, the onset was significantly delayed. These results indicate that the presence of LV can be involved in the pathogenesis of diabetes in these animal models.
653 a antibody treatment
653 a antiviral therapy
653 a viral infection
653 a MEDICINE
653 a MEDICIN
700a Klitz, William4 aut
700a Blixt, Martinu Uppsala universitet,Institutionen för medicinsk cellbiologi4 aut0 (Swepub:uu)mabli254
700a Berggren, Per-Olofu Karolinska Institutet4 aut
700a Juntti-Berggren, Lisau Karolinska Institutet4 aut
700a Niklasson, Bou Uppsala universitet,Institutionen för medicinsk cellbiologi4 aut0 (Swepub:uu)boani125
710a Uppsala universitetb Institutionen för medicinsk cellbiologi4 org
773t Microbiology and immunologyd : Wileyg 53:10, s. 567-572q 53:10<567-572x 0385-5600x 1348-0421
856u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1348-0421.2009.00160.x
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-127514
8564 8u https://doi.org/10.1111/j.1348-0421.2009.00160.x
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:119396952

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy